Y15

CAS No. 4506-66-5

Y15( 1245-Benzenetetramine tetrahydrochlor | FAK inhibitor Y15 | FAK Inhibitor 14 )

Catalog No. M20681 CAS No. 4506-66-5

Y15 is a potent and specificsmall-molecule FAK scaffolding inhibitor that inhibits its autophosphorylation activity blocks tumor growth.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 38 In Stock
10MG 41 In Stock
25MG 60 In Stock
50MG 70 In Stock
100MG 129 In Stock
200MG 184 In Stock
500MG 325 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Y15
  • Note
    Research use only, not for human use.
  • Brief Description
    Y15 is a potent and specificsmall-molecule FAK scaffolding inhibitor that inhibits its autophosphorylation activity blocks tumor growth.
  • Description
    Y15 is a potent and specificsmall-molecule FAK scaffolding inhibitor that inhibits its autophosphorylation activity blocks tumor growth.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    1245-Benzenetetramine tetrahydrochlor | FAK inhibitor Y15 | FAK Inhibitor 14
  • Pathway
    Angiogenesis
  • Target
    FAK
  • Recptor
    FAK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4506-66-5
  • Formula Weight
    284.01
  • Molecular Formula
    C6H14Cl4N4
  • Purity
    >98% (HPLC)
  • Solubility
    H2O:59 mg/mL (207.74 mM; Need ultrasonic and warming)
  • SMILES
    Cl.Cl.Cl.Cl.Nc1cc(N)c(N)cc1N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.O'Brien S Golubovskaya VM Conroy Jet al.FAK inhibition with small molecule inhibitor Y15 decreases viability clonogenicity and cell attachment in thyroid cancer cell lines and synergizes with targeted therapeutics[J].Oncotarget. 2014 Sep 15;5(17):7945-59.
molnova catalog
related products
  • GSK215

    GSK215 is a potent and selective PROTAC focal adhesion kinase (FAK) degrader (pDC50= 8.4), designed using the FAK inhibitor VS-4718 and a binder for the VHL E3 ligase, capable of inducing rapid and prolonged FAK degradation.

  • NAMI-A

    NAMI-A, a ruthenium-based compound, selectively targets tumor metastasis by inhibiting cancer cell adhesion and migration.

  • PF-562271 HCl

    PF-562271 is a potent ATP-competitive reversible inhibitor of FAK with IC50 of 1.5 nM in cell-free assays.